White blood cell count is associated with carotid and femoral atherosclerosis

Atherosclerosis

Volumn 221, Issue 1, 2012, Pages 275-281

  Ortega, Emilio ^a,b   Gilabert, Rosa ^a   Nuñez, Isabel ^a,c   Cofán, Montserrat ^a,c   Sala Vila, Aleix ^a,c   de Groot, Eric ^d   Ros, Emili ^a,c  

^a HOSPITAL CLÍNIC   (Spain)

^b INSTITUTO DE SALUD CARLOS III   (Spain)

^c INSTITUTO DE SALUD CARLOS III   (Spain)

^d UNIVERSITY OF AMSTERDAM   (Netherlands)

Author keywords

Atherosclerosis; Carotid; Femoral; Inflammation; Intima media thickness; Plaque; White blood cells

Indexed keywords

APOLIPOPROTEIN A1; APOLIPOPROTEIN B; C REACTIVE PROTEIN; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; TRIACYLGLYCEROL;

ADULT; AGE; ARTERIAL WALL THICKNESS; ARTICLE; ATHEROSCLEROSIS; ATHEROSCLEROTIC PLAQUE; BODY MASS; CARDIOVASCULAR RISK; CAROTID ATHEROSCLEROSIS; CHOLESTEROL BLOOD LEVEL; CIGARETTE SMOKING; CONTROLLED STUDY; CROSS-SECTIONAL STUDY; DIASTOLIC BLOOD PRESSURE; DISEASE SEVERITY; DYSLIPIDEMIA; FAMILY HISTORY; FEMALE; FEMORAL ATHEROSCLEROSIS; HUMAN; HYPERTENSION; INTRAVASCULAR ULTRASOUND; LEUKOCYTE COUNT; LIPOPROTEIN BLOOD LEVEL; MAJOR CLINICAL STUDY; MALE; MEDICAL HISTORY; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; SEX DIFFERENCE; SYSTOLIC BLOOD PRESSURE; TRIACYLGLYCEROL BLOOD LEVEL;

ADULT; ATHEROSCLEROSIS; C-REACTIVE PROTEIN; CAROTID ARTERY DISEASES; CAROTID INTIMA-MEDIA THICKNESS; CASE-CONTROL STUDIES; CROSS-SECTIONAL STUDIES; FEMALE; FEMORAL ARTERY; HUMANS; INFLAMMATION MEDIATORS; LEUKOCYTE COUNT; LINEAR MODELS; LOGISTIC MODELS; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; ODDS RATIO; PREDICTIVE VALUE OF TESTS; RISK ASSESSMENT; RISK FACTORS; SPAIN;

EID: 84857033057     PISSN: 00219150     EISSN: 18791484     Source Type: Journal    
DOI: 10.1016/j.atherosclerosis.2011.12.038     Document Type: Article

References (40)

1. Greenland P., Alpert J.S., Beller G.A., et al. 2010 ACCF/AHA guideline for assessment of cardiovascular risk in asymptomatic adults: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines. J Am Coll Cardiol 2010, 56:e50-e103.
2. Touboul P.J., Vicaut E., Labreuche J., et al. Correlation between the Framingham risk score and intima media thickness: the Paroi Arterielle et Risque Cardio-vasculaire (PARC) study. Atherosclerosis 2007, 192:363-369.
3. Lorenz M.W., Markus H.S., Bots M.L., Rosvall M., Sitzer M. Prediction of clinical cardiovascular events with carotid intima-media thickness: a systematic review and meta-analysis. Circulation 2007, 115:459-467.
4. Nambi V., Chambless L., Folsom A.R., et al. Carotid intima-media thickness and presence or absence of plaque improves prediction of coronary heart disease risk: the ARIC (Atherosclerosis Risk In Communities) study. J Am Coll Cardiol 2010, 55:1600-1607.
5. Gasparyan A.Y. The use of carotid artery ultrasonography in different clinical conditions. Open Cardiovasc Med J 2009, 3:78-80.
6. Gasparyan A.Y., Stavropoulos-Kalinoglou A., Mikhailidis D.P., et al. The rationale for comparative studies of accelerated atherosclerosis in rheumatic diseases. Curr Vasc Pharmacol 2010, 8:437-449.
7. Baldassarre D., Nyyssonen K., Rauramaa R., et al. Cross-sectional analysis of baseline data to identify the major determinants of carotid intima-media thickness in a European population: the IMPROVE study. Eur Heart J 2010, 31:614-622.
8. Paternoster L., Martinez-Gonzalez N.A., Charleton R., Chung M., Lewis S., Sudlow C.L. Genetic effects on carotid intima-media thickness: systematic assessment and meta-analyses of candidate gene polymorphisms studied in more than 5000 subjects. Circ Cardiovasc Genet 2010, 3:15-21.
9. Liese A.D., Nichols M., Hodo D., et al. Food intake patterns associated with carotid artery atherosclerosis in the Insulin Resistance Atherosclerosis Study. Br J Nutr 2010, 103:1471-1479.
10. Sala-Vila A., Cofan M., Perez-Heras A., et al. Fatty acids in serum phospholipids and carotid intima-media thickness in Spanish subjects with primary dyslipidemia. Am J Clin Nutr 2010, 92:186-193.
11. Danesh J., Whincup P., Walker M., et al. Low grade inflammation and coronary heart disease: prospective study and updated meta-analyses. BMJ 2000, 321:199-204.
12. Hansson G.K. Inflammation, atherosclerosis, and coronary artery disease. N Engl J Med 2005, 352:1685-1695.
13. Brown D.W., Giles W.H., Croft J.B. White blood cell count: an independent predictor of coronary heart disease mortality among a national cohort. J Clin Epidemiol 2001, 54:316-322.
14. Ernst E., Resch K.L. Fibrinogen as a cardiovascular risk factor: a meta-analysis and review of the literature. Ann Intern Med 1993, 118:956-963.
15. Kannel W.B., Anderson K., Wilson P.W. White blood cell count and cardiovascular disease Insights from the Framingham Study. JAMA 1992, 267:1253-1256.
16. Muscari A., Bozzoli C., Puddu G.M., et al. Association of serum C3 levels with the risk of myocardial infarction. Am J Med 1995, 98:357-364.
17. Ridker P.M., Cushman M., Stampfer M.J., Tracy R.P., Hennekens C.H. Inflammation, aspirin, and the risk of cardiovascular disease in apparently healthy men. N Engl J Med 1997, 336:973-979.
18. Junyent M., Gilabert R., Nunez I., et al. Carotid ultrasound in the assessment of preclinical atherosclerosis. Distribution of intima-media thickness values and plaque frequency in a Spanish community cohort. Med Clin (Barc) 2005, 125:770-774.
19. Junyent M., Gilabert R., Nunez I., et al. Femoral ultrasound in the assessment of preclinical atherosclerosis. Distribution of intima-media thickness and frequency of atheroma plaques in a Spanish community cohort. Med Clin (Barc) 2008, 131:566-571.
20. Junyent M., Gilabert R., Zambon D., et al. Femoral atherosclerosis in heterozygous familial hypercholesterolemia: influence of the genetic defect. Arterioscler Thromb Vasc Biol 2008, 28:580-586.
21. Junyent M., Zambon D., Gilabert R., et al. Carotid atherosclerosis and vascular age in the assessment of coronary heart disease risk beyond the Framingham Risk Score. Atherosclerosis 2008, 196:803-809.
22. Dehnavi R.A., de Roos A., Rabelink T.J., et al. Elevated CRP levels are associated with increased carotid atherosclerosis independent of visceral obesity. Atherosclerosis 2008, 200:417-423.
23. Alizadeh D.R., Beishuizen E.D., van de Ree M.A., et al. The impact of metabolic syndrome and CRP on vascular phenotype in type 2 diabetes mellitus. Eur J Intern Med 2008, 19:115-121.
24. Blackburn R., Giral P., Bruckert E., et al. Elevated C-reactive protein constitutes an independent predictor of advanced carotid plaques in dyslipidemic subjects. Arterioscler Thromb Vasc Biol 2001, 21:1962-1968.
25. Chapman C.M., Beilby J.P., McQuillan B.M., Thompson P.L., Hung J. Monocyte count, but not C-reactive protein or interleukin-6, is an independent risk marker for subclinical carotid atherosclerosis. Stroke 2004, 35:1619-1624.
26. Hak A.E., Stehouwer C.D., Bots M.L., et al. Associations of C-reactive protein with measures of obesity, insulin resistance, and subclinical atherosclerosis in healthy, middle-aged women. Arterioscler Thromb Vasc Biol 1999, 19:1986-1991.
27. Huang Z.S., Jeng J.S., Wang C.H., et al. Correlations between peripheral differential leukocyte counts and carotid atherosclerosis in non-smokers. Atherosclerosis 2001, 158:431-436.
28. Loimaala A., Rontu R., Vuori I., et al. Blood leukocyte count is a risk factor for intima-media thickening and subclinical carotid atherosclerosis in middle-aged men. Atherosclerosis 2006, 188:363-369.
29. Temelkova-Kurktschiev T., Koehler C., Henkel E., Hanefeld M. Leukocyte count and fibrinogen are associated with carotid and femoral intima-media thickness in a risk population for diabetes. Cardiovasc Res 2002, 56:277-283.
30. Willeit J., Kiechl S., Oberhollenzer F., et al. Distinct risk profiles of early and advanced atherosclerosis: prospective results from the Bruneck Study. Arterioscler Thromb Vasc Biol 2000, 20:529-537.
31. Touboul P.J., Hennerici M.G., Meairs S., et al. Mannheim intima-media thickness consensus. Cerebrovasc Dis 2004, 18:346-349.
32. Madjid M., Awan I., Willerson J.T., Casscells S.W. Leukocyte count and coronary heart disease: implications for risk assessment. J Am Coll Cardiol 2004, 44:1945-1956.
33. Frohlich M., Imhof A., Berg G., et al. Association between C-reactive protein and features of the metabolic syndrome: a population-based study. Diabetes Care 2000, 23:1835-1839.
34. Mendall M.A., Patel P., Ballam L., Strachan D., Northfield T.C. C reactive protein and its relation to cardiovascular risk factors: a population based cross sectional study. BMJ 1996, 312:1061-1065.
35. Steinvil A., Berliner S., Herishanu Y., et al. Range and determinants of white blood cell count in a large survey of Israelis without inflammation. Isr Med Assoc J 2009, 11:363-366.
36. Marques-Vidal P., Bochud M., Bastardot F., et al. Levels and determinants of inflammatory biomarkers in a Swiss population-based sample (CoLaus Study). PLoS ONE 2011, 6:e21002.
37. Dalager S., Paaske W.P., Kristensen I.B., Laurberg J.M., Falk E. Artery-related differences in atherosclerosis expression: implications for atherogenesis and dynamics in intima-media thickness. Stroke 2007, 38:2698-2705.
38. Gariepy J., Salomon J., Denarie N., et al. Sex and topographic differences in associations between large-artery wall thickness and coronary risk profile in a French working cohort: the AXA Study. Arterioscler Thromb Vasc Biol 1998, 18:584-590.
39. Paul T.K., Chen W., Srinivasan S.R., He J., Berenson G.S. Contrast of the impact of multiple cardiovascular risk factors on the femoral and carotid intima-media thickness in asymptomatic young adults: the Bogalusa Heart Study. Atherosclerosis 2011, 216:359-364.
40. Gautier E.L., Jakubzick C., Randolph G.J. Regulation of the migration and survival of monocyte subsets by chemokine receptors and its relevance to atherosclerosis. Arterioscler Thromb Vasc Biol 2009, 29:1412-1418.